4Q2021 – International Small Company Growth Commentary

We remain focused on our goal of finding high-quality compounders

Read the full commentary here →

  • The end of 2021 marked the Polen International Small Company Growth strategy’s three-year anniversary. Since inception, we have delivered 24.23% gross and 23.00% net annualized returns and outperformed our benchmark by approximately 6.5% per year.
  • Over the fourth quarter of 2021, the Polen International Small Company Growth Composite Portfolio (the “Portfolio”) returned -0.25% gross and -0.50% net of fees, versus the 0.62% return for the MSCI ACWI ex-US Small Capitalization Index (the “Index”). Over the full-year 2021, the Portfolio returned 10.87% and 9.78% gross and net of fees, respectively, versus 12.92% for the Index.
  • The top absolute contributors to performance in 2021 were Endava, Thule, and Globant. The top three absolute detractors were Douzone Bizon, Cybozu, and CompuGroup Medical.
  • Our research shows that the companies we own are at the forefront of change in incredibly attractive industries, which should allow them to deliver durable, profitable growth.

Read the full commentary & disclosures here →